Autoimmune Disease Diagnosis Market

  • Published on 2025-11-10
  • Report Code: 419
  • 170-350 pages
Autoimmune Disease Diagnosis Market

Autoimmune Disease Diagnosis Market Segmentation: By Product (Consumables and Assay Kits, Instruments and others); By Test Type (Autoantibodies & Immunologic Test, Inflammatory Markers and Routine Laboratory Tests); By Disease (RA, SLE, Thyroiditis and Scleroderma); By End User (Hospitals, Clinical Labs and Others); By Type (Systemic Autoimmune Disease Diagnostics and Localized Autoimmune Disease Diagnostics) and Region - Analysis of Market Size, Share & Trends for 2017- 2019 and Forecasts to 2030

Table Of Content

 

Contents

  1. Executive Summary
  2. Autoimmune Disease Diagnosis
    1. AI for Drug Discovery Product Overview
    2. Market Definition
    3. Segmentation
    4. Assumptions and Acronyms
  3. Research Methodology
    1. Research Objectives
    2. Primary Research
    3. Secondary Research
    4. Forecast Model
    5. Market Size Estimation
  4. Average Pricing Analysis
  5. Market Dynamics
    1. Growth Drivers
    2. Restraints
    3. Opportunity
    4. Trends
  6. Recent Development, Policies & Regulatory Landscape
  7. Risk Analysis
    1. Demand Risk Analysis
    2. Supply Risk Analysis
  8. Autoimmune Disease Diagnosis Industry Analysis
    1. Porters Five Forces
      1. Threat of New Entrants
      2. Bargaining Power of Suppliers
      3. Threat of Substitutes
      4. Rivalry
    2. PEST Analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
  9. Global Autoimmune Disease Diagnosis Market
    1. Market Size & forecast, 2019A-2030F
      1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
  10. Global Autoimmune Disease Diagnosis: Market Segmentation
    1. By Regions
      1. North America: (U.S. and Canada) By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America) By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe) By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific) By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa) By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
    2. By Product: Market Share (2020-2030F)
      1. Consumables and Assay Kits, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      2. Instruments, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      3. Others, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
  11. By Test Type: Market Share (2020-2030F)
    1. Autoantibodies & Immunologic Test, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
    2. Inflammatory Markers Routine Laboratory Tests, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
    3. Routine Laboratory Tests, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
  12.   By Disease: Market Share (2020-2030F)
    1. .     RA Thyroiditis Scleroderma, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
    2.       SLE, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
    3.     Thyroiditis Scleroderma, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
    4.     Scleroderma, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
  13. . By Type: Market Share (2020-2030F)
    1.       Systemic Autoimmune Disease Diagnostics, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
    2.       Localized Autoimmune Disease Diagnostics, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
  14. . By End-users: Market Share (2020-2030F)
    1.       Hospitals, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
    2.       Clinical Labs, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
    3.       Others, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
  15. Company Profile
    1. Abbott (US)
      1. Company Overview
      2. Company Total Revenue (Financials)
      3. Market Potential
      4. Global Presence
      5. Key Performance Indicators
      6. SWOT Analysis
      7. Product Launch
    2. AESKU GROUP GMBH & CO. KG (Germany)
    3. Thermo Fisher Scientific (US)
    4. Danaher (US)
    5. HYCOR Biomedical (US)
    6. Siemens (Germany)
    7. Inova Diagnostics (US)
    8. Trinity Biotech (Ireland)
    9. Bio-Rad (US)
    10. GRIFOLS (Spain)

Consultant Recommendation

The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.

To request a free sample copy of this report, please complete the form below.

Select License Type

$ 4950

Report accessible by 1 user only

In case you require a hard copy, there will be an additional charge of $500. Please email us at [email protected] with your request.

Read all reports

Our Clients

We have been working with some Fortune 500+ clients